| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 159.60B | 155.84B | 148.59B | 150.96B | 148.07B | 139.08B |
| Gross Profit | 49.76B | 47.23B | 45.04B | 46.13B | 44.79B | 36.73B |
| EBITDA | 14.32B | 12.03B | 12.85B | 13.35B | 12.72B | 9.56B |
| Net Income | 7.48B | 6.04B | 6.74B | 6.72B | 6.02B | 2.58B |
Balance Sheet | ||||||
| Total Assets | 145.19B | 147.84B | 147.09B | 139.93B | 134.08B | 128.07B |
| Cash, Cash Equivalents and Short-Term Investments | 41.10B | 42.16B | 40.60B | 42.18B | 38.57B | 31.69B |
| Total Debt | 5.70B | 6.57B | 6.61B | 6.55B | 5.21B | 5.32B |
| Total Liabilities | 42.67B | 45.94B | 47.82B | 46.58B | 44.24B | 39.00B |
| Stockholders Equity | 102.38B | 101.70B | 99.08B | 93.16B | 89.61B | 86.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.46B | 4.44B | 9.68B | 12.38B | 5.46B |
| Operating Cash Flow | 0.00 | 7.57B | 6.47B | 11.13B | 13.50B | 5.86B |
| Investing Cash Flow | 0.00 | -2.02B | -4.71B | -8.33B | -1.35B | -3.95B |
| Financing Cash Flow | 0.00 | -4.05B | -3.41B | -3.14B | -4.79B | -1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥35.58B | 6.07 | ― | 1.67% | 7.33% | ― | |
70 Outperform | ¥919.57B | 21.98 | 5.45% | 1.30% | 4.55% | -7.49% | |
69 Neutral | ¥112.80B | 10.12 | ― | 1.71% | 7.01% | 72.94% | |
69 Neutral | ¥789.76B | 11.82 | 6.38% | 1.03% | 7.90% | 54.01% | |
64 Neutral | ¥340.11B | 6.57 | 7.48% | 1.79% | 6.63% | 80.44% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
53 Neutral | ¥619.35B | 25.92 | -2.45% | 1.40% | -6.29% | -141.32% |